博拓生物 (688767.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

现金流量表(博拓生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 386,481,114.18267,171,171.40142,208,566.66321,860,619.62306,663,848.39213,282,441.56105,347,961.65
 收到的税费返还(元) 11,024,554.138,513,778.251,523,581.9930,113,230.0433,157,916.072,213,787.942,425,058.98
 收到其他与经营活动有关的现金(元) 46,436,308.7134,650,596.3820,381,728.51121,396,448.2664,687,127.8037,942,314.8613,126,006.82
 经营活动现金流入小计(元) 443,941,977.02310,335,546.03164,113,877.16473,370,297.92404,508,892.26253,438,544.36120,899,027.45
 购买商品、接受劳务支付的现金(元) 174,260,935.07110,068,560.7454,780,648.88121,473,777.34203,169,176.86148,368,650.0084,548,715.19
 支付给职工以及为职工支付的现金(元) 88,905,690.3462,680,672.5334,847,929.27127,415,820.7092,032,685.9473,386,957.7836,902,488.23
 支付的各项税费(元) 36,700,190.1620,855,756.318,882,383.3733,596,422.0637,671,930.3026,624,322.4310,020,530.98
 支付其他与经营活动有关的现金(元) 35,057,081.4024,100,141.769,078,850.3059,503,500.8635,144,575.5724,076,640.479,488,821.68
 经营活动现金流出小计(元) 334,923,896.97217,705,131.34107,589,811.82341,989,520.96368,018,368.67272,456,570.68140,960,556.08
 经营活动产生的现金流量净额平衡项目(元) ---0.010.01--
 经营活动产生的现金流量净额(元) 109,018,080.0592,630,414.6956,524,065.34131,380,776.9736,490,523.60-19,018,026.32-20,061,528.63
二、投资活动产生的现金流量
 收回投资收到的现金(元) 3,607,000,000.001,185,600,000.0010,000,000.00130,564,516.13120,500,000.00100,500,000.00-
 取得投资收益收到的现金(元) 5,605,046.361,485,587.3915,205.483,839,444.913,744,810.353,355,550.09364,931.52
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) ---182,489.29---
 投资活动现金流入小计(元) 3,612,605,046.361,187,085,587.3910,015,205.48134,586,450.33124,244,810.35103,855,550.09364,931.52
 购建固定资产、无形资产和其他长期资产支付的现金(元) 232,270,705.08181,841,583.76168,182,750.8756,424,000.2913,435,045.7111,674,945.719,157,085.00
 投资支付的现金(元) 3,648,823,550.001,275,600,000.00-3,800,000.003,803,850.52500,000.00500,000.00
 投资活动现金流出小计(元) 3,881,094,255.081,457,441,583.76168,182,750.8760,224,000.2917,238,896.2312,174,945.719,657,085.00
 投资活动产生的现金流量净额(元) -268,489,208.72-270,355,996.37-158,167,545.3974,362,450.04107,005,914.1291,680,604.38-9,292,153.48
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ---4,172,742.004,176,592.524,176,592.52-
  其中:子公司吸收少数股东投资收到的现金(元) ----4,176,592.524,176,592.52-
 取得借款收到的现金(元) ---239,739.04202,837.92202,837.92-
 筹资活动现金流入小计(元) ---4,412,481.044,379,430.444,379,430.44-
 偿还债务支付的现金(元) 289,741.7966,325.02--372,052.44--
 分配股利、利润或偿付利息支付的现金(元) 81,936,212.6681,936,212.66-234,666,667.40234,666,667.40225,970,260.51-
 支付其他与筹资活动有关的现金(元) 44,969,473.5686,355,927.3340,676,446.4218,932,909.806,084,145.001,354,104.73660,157.55
 筹资活动现金流出小计(元) 127,195,428.01168,358,465.0140,676,446.42253,599,577.20241,122,864.84227,324,365.24660,157.55
 筹资活动产生的现金流量净额(元) -127,195,428.01-168,358,465.01-40,676,446.42-249,187,096.16-236,743,434.40-222,944,934.80-660,157.55
四、汇率变动对现金及现金等价物的影响(元) -10,692,163.364,235,718.48793,773.2510,893,771.0819,084,474.3123,082,443.99-14,501,234.85
五、现金及现金等价物净增加额(元) -297,358,720.04-341,848,328.21-141,526,153.22-32,550,098.07-74,162,522.37-127,199,912.75-44,515,074.51
 加:期初现金及现金等价物余额(元) 1,907,238,695.681,907,238,695.681,907,238,695.681,939,788,793.751,939,788,793.751,939,788,793.751,939,980,793.75
 期末现金及现金等价物余额(元) 1,609,879,975.641,565,390,367.471,765,712,542.461,907,238,695.681,865,626,271.381,812,588,881.001,895,465,719.24
补充资料:
 净利润(元) -70,436,116.29-105,299,800.71-60,963,005.47-
 资产减值准备(元) -5,568,017.27-55,274,643.20-7,678,902.64-
 固定资产和投资性房地产折旧(元) -11,878,180.26-18,136,334.62-8,900,122.06-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) -11,878,180.26-18,136,334.62-8,900,122.06-
 无形资产摊销(元) -3,039,296.65-6,539,942.56-3,024,677.84-
 长期待摊费用摊销(元) -54,470.13-104,655.60-54,228.61-
 处置固定资产、无形资产和其他长期资产的损失(元) -49,756.60--2,262.49-104,518.57-
 固定资产报废损失(元) -4,615.61-1,082,907.65-76.56-
 公允价值变动损失(元) -----64,516.13-
 财务费用(元) --4,212,798.49--12,321,445.25--22,288,733.44-
 投资损失(元) --1,022,177.34--3,379,945.24--3,355,550.09-
 递延所得税(元) -1,516,487.97--1,738,530.53--114,461.88-
  其中:递延所得税资产减少(元) -1,516,487.97--1,285,645.78--250,067.16-
 递延所得税负债增加(元) ----452,884.75-135,605.28-
 存货的减少(元) -13,289,102.30--14,142,542.08-9,118,797.07-
 经营性应收项目的减少(元) -27,899,619.31--13,569,078.68--28,457,047.68-
 经营性应付项目的增加(元) --40,099,931.95--20,426,949.61--62,344,054.25-
 其他(元) -2,441,863.47-2,464,809.38-2,906,936.38-
 现金的期末余额(元) -1,565,390,367.47-1,907,238,695.68-1,812,588,881.00-
 减:现金的期初余额(元) -1,907,238,695.68-1,939,788,793.75-1,939,788,793.75-
 现金及现金等价物的净增加额(元) --341,848,328.21--32,550,098.07--127,199,912.75-
公告日期 2024-10-302024-08-302024-04-272024-04-272023-10-282023-08-302023-04-29
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院